TEBONIN Forte 40 mg film -coated tablets, 200 pcs

Instructions for use for TEBONIN Forte 40 mg film -coated tablets, 200 pcs

Detailed instructions for TEBONIN Forte 40 mg film -coated tablets, 200 pcs

Field of use

• The medicine is a blood circulation-promoting vegetable medicine and contains an extract made of ginkgo leaves.
• The medicine is taken
  • For the symptomatic treatment of braingian -caused performance disorders in the context of a therapeutic overall concept of therapeutic concept in dementia syndromes (brain performance disorders with dismantling mental performance) with the leading symptoms (the main complaints):
    • Memory disorders, concentration disorders, depressive mood, dizziness, ears of the ears, headaches.
  • The primary target group includes patients with dementia syndrome with primarily degenerative dementia, vascular dementia and mixed forms from both (brain performance disorders with dismantling mental performance as a result of regression processes or circulatory disorders in the brain or mixed forms of both).
  • Notice
    • Before treatment with the medicine is started, it should be clarified whether the symptoms of illness are not based on a basic disease that can be treated specifically (by separate therapy measures).
  • To extend the pain-free walking distance in peripheral arterial closure disease in stage II according to Fontaine (Claudicatio intermittent, "shop window disease") in the context of physical-therapeutic measures, in particular walking training.
  • In the event of dizziness, tinnitus (ear noises) vascular and involved (as a result of circulatory disorders or age -related regulations).
  • Hints
    • If the memory disorders, the concentration disorders or the headache keep for more than 3 months despite the prescription application of the drug, a doctor should be consulted because it can be illnesses that require medical clarification.
    • Depressive moods or frequently occurring dizziness and ears of the ears basically need to clarify by a doctor.

To treat complaints in braingian -related mental performance losses in the context of a therapeutic overall concept of the intellectual skills (demential syndrome) acquired with the main complaints: memory disorders, depression, dizziness, breastfeeding, headache. Before treatment with Ginkgo extract begins, it should be clarified whether the disease complaints are not based on a specifically treated underlying disease.

Active ingredients / ingredients / ingredients

Ginkgo leaves dry extract, (35-67: 1), extractor: acetone 60% (m/m)
9.6 mg ginkgo flavonoid glycosides
0.2 µg ginkgolic acids
Ginkgolide A+B+C
Bilobalide
2.4 mg Terpenlactone
Cellulose, microcrystalline auxiliary material (+)
Crooscarmellosis, sodium salt auxiliary material (+)
Iron (III) hydroxide oxide x-water Hedge substance (+)
Hypromellic auxiliary substance (+)
Lactose 1-water auxiliary substance (+)
Macrogol 1500 Hedge substance (+)
Magnesium stair auxiliary material (+)
Corn starch auxiliary substance (+)
Silicium dioxide, high disperser auxiliary substance (+)
Simeticon-alpha-hydro-omega-octadecyloxypoly (oxyethylene) -5- (e, e) hexa-2,4-fan water auxiliary material (+)
Talcum auxiliary material (+)
Titan dioxide HILDBOFT (+)

Contradictions

• The medicine must not be taken
  • wEnN are hypersensitive (allergic) against the drug component or one of the other components of the medicine.

dosage

• Always take the medicine exactly according to the instruction.
• Please ask your doctor or pharmacist if you are not quite sure.
• Unless otherwise prescribed by the doctor, the usual dose is
  • For the symptomatic treatment of braingian -related performance disorders, take 1 - 2 tablets 3 times a day.
  • To extend the pain -free walking distance with peripheral arterial closure disease, take 1½ - 2 tablets twice a day.
  • In the event of dizziness and ear noise, more vascular and involved, take 1½ - 2 tablets twice a day.

 

• Duration of the application
  • In the case of brainganic performance disorders, the treatment period should be at least 8 weeks.
  • After a treatment period of 3 months, the doctor must check whether the continuation of the treatment is still justified.
  • In the case of arterial closure disease in the limbs
    • An improvement in walking performance requires a treatment duration of at least 6 weeks.
  • With dizziness
    • The application over a longer period of time than 6 to 8 weeks does not improve the result of the treatment.
  • With ear noise
    • Supporting treatment should take place over a period of at least 12 weeks. If no success has occurred after 6 months, it can no longer be expected even during longer treatment.
  • Please speak to your doctor or pharmacist if you have the impression that the effect of the medicine is too strong or too weak.

 

• If you have taken a larger amount of the medicine than you should
  • The side effects listed below may occur increased; In this case, please notify a doctor. This may decide on the necessary measures.

 

• If you forgot to take the medicine
  • Next time, do not take the twice the amount, but continue with taking you, as prescribed by your doctor or described as described here.

 

• If you have any further questions about the application of the drug, ask your doctor or pharmacist.

Taking

• To take
• Do not take the drug while lying down.
• Please take the medicine with sufficient liquid (preferably a glass of drinking water).
• The application takes place in the morning, at noon and in the evening, with 2 times daily application in the morning and in the evening.
• The intake can take place independently of the meals.
• Application note
  • To divide, put the tablet with the Bruchkerbe up on a fixed surface.
  • With slight pressure with the thumb you halve the tablet.

Patient information

• Particular caution when taking the medicine is required
  • In the event of pathologically increased bleeding tendency (hemorrhagic diathesis) and at the same time treatment with anticoagulant medicines, this medicine should only be used after consultation with a doctor.
  • Since there is indications that ginkgo-containing preparations can increase the willingness to bleed, this medicine must be discontinued before surgery. Please inform your doctor in good time, who will decide on how to proceed.
  • Children
    • There is no sufficient examinations for the use of this drug in children. It should therefore not be used in children under the age of 12.

 

• Wateriness and operating machines
  • There are no special precautions required.

Pregnancy

• Pregnancy and breast feeding period
  • Questionyou your doctor or pharmacist for advice before taking/using all medicines.
  • Pregnancy
    • Experimental studies have given no indication of a fruit-damaging effect of the Ginkgo extract contained in this medicine.
    • However, since there is no experience in humans and the application during pregnancy is not justified, the benefit of treatment during pregnancy must be carefully weighed up against the possible risks.
  • Breastfeeding
    • It is not known whether the ingredients of the Ginkgo extract change into breast milk.

Hints

Miscellaneous

- If the memory disorders, the concentration disorders or headaches, despite the prescription application of the medicine, keep for more than 3 months, should a doctor be consulted because it can be illnesses that require medical clarification.
- Sad moods or frequently occurring dizziness and the ears of the ears basically require a doctor to clarify.
- A doctor should be consulted immediately if hearing loss or hearing loss occurs.
- If hypersensitivity reactions of the skin or in the event of persistent headache or gastrointestinal complaints, a doctor should be consulted so that he can clarify whether there is a connection with the use of GinkGO extract or whether the symptoms are based on another cause.
- The individual response to the medication cannot be predicted.

Manufacturer:  Dr.Willmar Schwabe GmbH & Co.KG, Willmar-Schwabe-Straße 4, 76227 Karlsruhe